pISSN 2234-3806
eISSN 2234-3814
Cited by CrossRef (9)
- Kyung-Hwa Shin, Sun Min Lee, Kongkyoung Park, Hyunji Choi, In-suk Kim, Seong Hoon Yoon, Seung Hwan Oh. Effects of Different Centrifugation Protocols on the Detection of EGFR Mutations in Plasma Cell-Free DNA. 2022;158:206
- Ricella Souza da Silva, Fernando Schmitt. Minimally Invasive, Maximally Effective. Surgical Pathology Clinics 2024;17:453
- Wei Wu, Yan Huang, Junhong Guo, Xiaofeng Xie, Hui Li, Ziyang Cao, Haiting Wei, Chunyan Wu. Detection and comparison of EGFR mutations from supernatants that contain cell‐free DNA and cell pellets from FNA non–small cell lung cancer specimens. Cancer Cytopathology 2020;128:545
- Seung-Myoung Son, Chang Gok Woo, Hye Sook Han, Ki Hyeong Lee, Young Hyun Lim, Ok-Jun Lee. Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma. 2020;58:1547
- Si-Yang Maggie Liu, Zhen-Yi Jin, Jia-Yi Deng, Si-Min Zhong, Myung-Ju Ahn, Hidehito Horinouchi, Yangqiu Li, Yi-Long Wu. Drug development and evidence for lung cancer targeted therapy in Eastern Asia. The Lancet Regional Health - Western Pacific 2024;49:101090
- Ângela Carvalho, Gabriela Ferreira, Duarte Seixas, Catarina Guimarães-Teixeira, Rui Henrique, Fernando J. Monteiro, Carmen Jerónimo. Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation. Cancers 2021;13:2101
- Yong Gon Cho, Joonhong Park, Ji Yoon Han, Tae Yun Kim. Evaluation of the Analytical Performance of Oncomine Lung cfDNA Assay for Detection of Plasma EGFR Mutations. Genes 2023;14:1219
- Aleksandra Bożyk, Marcin Nicoś. The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer. Life 2022;12:1640
- Sunyoung Ahn, Hyun-Ki Kim, Ji Hyun Kim, Woochang Lee, Sail Chun, Wee Gyo Lee, Won-Ki Min. Development of an Operational Plan for the Liquid Biopsy External Quality Assessment Program in Korea. Lab Med Qual Assur 2020;42:91